Clinical Trial Update: Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a caffeine-based antifibrosis cream for safety and efficacy in breast cancer patients undergoing radiation therapy; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Caffeine-based antifibrosis cream (caffeine-based antifibrosis topical formulation)

Snippet

Sponsor: NYU Langone Health | Conditions: Carcinoma Breast | Phase 2 | Status: ACTIVE_NOT_RECRUITING